Is ASLN or JEPQ a better dividend investment in 2026?

ASLN currently yields 333.33% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: ASLN offers higher current income.

What is the dividend yield difference between ASLN and JEPQ?

ASLN has a forward dividend yield of 333.33% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 322.23 percentage points.

Home › Compare › ASLN vs JEPQ

ASLN vs JEPQ: Dividend Comparison 2026

ASLN yields 333.33% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ASLN wins by $3112.20M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ASLN

● Live price

333.33%

Share price

$0.60

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3112.25M

Annual income

$1,957,209,378.70

Full ASLN calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — ASLN vs JEPQ

📍 ASLN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ASLN	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ASLN + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ASLN pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASLN

Annual income on $10K today (after 15% tax)

$28,333.33/yr

After 10yr DRIP, annual income (after tax)

$1,663,627,971.90/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, ASLN beats the other by $1,663,626,142.19/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASLN + JEPQ for your $10,000?

ASLN: 50%JEPQ: 50%

100% JEPQ50/50100% ASLN

Portfolio after 10yr

$1556.15M

Annual income

$978,605,765.64/yr

Blended yield

62.89%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ASLN right now

ASLN

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-14.9

Piotroski

3/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASLN buys

JEPQ buys

No recent congressional trades found for ASLN or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricASLNJEPQ

Forward yield	333.33% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$3112.25M ✓	$44.8K
Annual income after 10y	$1,957,209,378.70 ✓	$2,152.59
Total dividends collected	$3000.20M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ASLN vs JEPQ ($10,000, DRIP)

Year	ASLN Portfolio	ASLN Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$44,033	$33,333.33	$11,930	$1,110.39	+$32.1K → ASLN
2	$184,291	$137,175.49	$14,133	$1,224.34	+$170.2K → ASLN
3	$733,748	$536,556.79	$16,632	$1,340.46	+$717.1K → ASLN
4	$2,781,635	$1,996,524.01	$19,454	$1,457.97	+$2.76M → ASLN
5	$10,050,002	$7,073,652.70	$22,626	$1,576.08	+$10.03M → ASLN
6	$34,638,543	$23,885,041.43	$26,175	$1,694.09	+$34.61M → ASLN
7	$114,000,322	$76,937,080.16	$30,133	$1,811.32	+$113.97M → ASLN
8	$358,625,914	$236,645,569.53	$34,531	$1,927.17	+$358.59M → ASLN
9	$1,079,474,884	$695,745,156.26	$39,403	$2,041.08	+$1079.44M → ASLN
10	$3,112,247,504	$1,957,209,378.70	$44,787	$2,152.59	+$3112.20M → ASLN

ASLN vs JEPQ: Complete Analysis 2026

ASLN — Stock

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

Full ASLN Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this ASLN vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASLN vs SCHD ASLN vs JEPI ASLN vs O ASLN vs KO ASLN vs MAIN ASLN vs XYLD ASLN vs QYLD ASLN vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.